GT Biopharma Inc (GTBP)

[FinanceAngel]

Early stage testing has shown great promise. Working in collaboration with Dr. Jeffrey Miller of Univ. of Minnesota, recognized leader in immuno oncology, the drug OXS-1550 has been used successfully and seen patients suffering from lyphoma go into remission. One patient, a physics professor from the U of Minnesota, was suffering from late stage lymphoma and had endured many types of conventional and experimental therapies all to no avail. Upon admnistration of two doses of OXS-1550, she was amazed not only to go into total remission, but to be able to do things like jog around the lake, something that the side effects of non-targeted therapies like chemo or radiation would never have allowed.